0001014739-11-000010.txt : 20110404 0001014739-11-000010.hdr.sgml : 20110404 20110404170526 ACCESSION NUMBER: 0001014739-11-000010 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110404 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20110404 DATE AS OF CHANGE: 20110404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioScrip, Inc. CENTRAL INDEX KEY: 0001014739 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 050489664 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28740 FILM NUMBER: 11736732 BUSINESS ADDRESS: STREET 1: 100 CLEARBROOK ROAD CITY: ELMSFORD STATE: NY ZIP: 10523 BUSINESS PHONE: 914 460 1600 MAIL ADDRESS: STREET 1: 100 CLEARBROOK ROAD CITY: ELMSFORD STATE: NY ZIP: 10523 FORMER COMPANY: FORMER CONFORMED NAME: MIM CORP DATE OF NAME CHANGE: 19960516 8-K 1 form8k.htm FORM 8-K form8k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
______________________________________________
 
 
 
FORM 8-K
 
 
______________________________________________
 
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) March 31, 2011
 
 
______________________________________________
 
 
BIOSCRIP, INC.
 
(Exact name of Registrant as specified in its charter)
 
 
______________________________________________
 
 

 
 
Delaware                                                                                                                                         0-28740                                                                                                                               05-0489664
(State of Incorporation)                    (Commission File Number)                                                                                                      (I.R.S. Employer
                                                                                                                                                                                                                                                                                                     Identification No.)
 
 100 Clearbrook Road, Elmsford, New York                                                                                                                                                                   10523
(Address of principal executive offices)                                                                                                                                                                     (Zip Code)
 
 
Registrant’s telephone number, including area code: (914) 460-1600
 
N/A
(Former name or former address, if changed since last report)
 
______________________________________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
 
 
(b) Departure of Principal Accounting Officer
 
On March 31, 2011, the employment of Mr. Phillip Keller, Vice President of Finance and Principal Accounting Officer of BioScrip, Inc. (the "Company") was terminated.
 
 
(c) Appointment of Principal Accounting Officer
 
In addition, effective April 1, 2011, Ms. Patricia Bogusz, the Company’s Vice President - Controller was appointed Vice President of Finance and has been named Principal Accounting Officer to replace Mr. Keller. Ms. Boguz joined the Company in October of 2005 as Director of Internal Audit. In June of 2007, Ms. Boguz was promoted to Vice President - Controller.
 
 
 
2
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
                                                          BIOSCRIP, INC.
 
 
 
Date: April 4,  2011                                                    /s/ Barry A. Posner                                              
                                                          By:  Barry A. Posner
                                                                  Executive Vice President, Secretary and General Counsel
 
 
 
3